TrialBritish journal of cancer2016

Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial.

Niall C Tebbutt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.